<?xml version="1.0" encoding="UTF-8"?>
<ref id="B61">
 <label>61</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Neelapu</surname>
    <given-names>SS</given-names>
   </name>
   <name>
    <surname>Tummala</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Kebriaei</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Wierda</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Gutierrez</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Locke</surname>
    <given-names>F</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Chimeric antigen receptor T-cell therapy-assessment and management of toxicities</article-title>. 
  <source>Nat Rev Clin Oncol</source> (
  <year>2018</year>) 
  <volume>15</volume>(
  <issue>1</issue>):
  <fpage>47</fpage>–
  <lpage>62</lpage>.  
  <pub-id pub-id-type="doi">10.1038/nrclinonc.2017.148</pub-id>
  <pub-id pub-id-type="pmid">28925994</pub-id>
 </mixed-citation>
</ref>
